MiNK Therapeutics Sets Third-Quarter Results Release

Bitget2026/11/02 21:46

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

MiNK Therapeutics will report third-quarter 2026 results before the market opens on Nov. 11, 2026.
A conference call and webcast on Nov. 11 at 8:30 a.m. ET will review results and clinical development priorities.
The update will cover agenT-797’s randomized Phase 2 evaluation, scalable cell therapy technologies and cancer treatment programs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mink Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611021635PRIMZONEFULLFEED9868470) on November 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

MiNK Therapeutics Sets Third-Quarter Results Release

You may also like

Crypto prices